ENTRECTINIB IN PATIENTS WITH ADVANCED OR METASTATIC NTRK FUSION-POSITIVE SOLID TUMOURS: INTEGRATED ANALYSIS OF THREE PHASE 1–2 TRIALS

Sunday, July 26, 2020

Read the Story Here

Related Posts

Discover more posts like this.

PHASE 1 FIRST-IN- HUMAN STUDY OF DALUTRAFUSP ALFA,

Cluster of differentiation (CD)73-adenosine and transforming growth factor (TGF)-β pathways are involved in abrogated antitumor immune responses and can lead to protumor conditions....

Jul 26, 2023

RARE SOLID AND CYSTIC PRESENTATION OF HEMANGIOPERICYTOMA/ SOLITARY FIBROUS TUMOR: A CASE REPORT

Jul 26, 2022

MANUFACTURING-DEPENDENT CHANGE IN BIOLOGICAL ACTIVITY OF THE TLR4 AGONIST GSK1795091

Jul 26, 2022
See All Posts